⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5840333 | 0.88 | ALDH1A1 (0.41) | — | |
| SCHEMBL2210621 | 0.80 | — | — | |
| SCHEMBL777321 | 0.79 | ALDH1A1 (0.52) | — | |
| SCHEMBL3913999 | 0.79 | ALDH1A1 (0.46) | — | |
| SCHEMBL3294656 | 0.78 | — | — | |
| SCHEMBL26385508 | 0.77 | — | — | |
| SCHEMBL3406583 | 0.77 | — | — | |
| SCHEMBL9185106 | 0.76 | ALDH1A1 (0.50) | — | |
| SCHEMBL5461072 | 0.76 | ALDH1A1 (0.50) | — | |
| SCHEMBL7021059 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113444059-B | Process for preparing 2- (methylsulfonyl) -oxirane and derivatives thereof | 河北圣泰材料股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-113444059-A | Process for the preparation of 2- (methylsulfonyl) -oxirane and derivatives thereof | 石家庄圣泰化工有限公司 | 2021-09-28 | — | — | CN | claimed |
| US-12157751-B2 | Process for the synthesis of oligomeric siloxane having sulfone moiety, and silicon-containing compounds having sulfone moiety | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-12-03 | — | — | US | disclosed |
| CN-113444059-B | Process for preparing 2- (methylsulfonyl) -oxirane and derivatives thereof | 河北圣泰材料股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117279925-A | Method for synthesizing oligomeric siloxanes having sulfone moieties and silicon-containing compounds having sulfone moieties | 迈图高新材料公司 | 2023-12-22 | — | — | CN | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230312617-A1 | PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230312617-A1 | PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-10-05 | — | — | US | disclosed |
| CN-116829565-A | Method for synthesizing organosilicon compounds from halosilanes | 迈图高新材料公司 | 2023-09-29 | — | — | CN | disclosed |
| US-20230246229-A1 | ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES | Octet Scientific, Inc. | 2023-08-03 | — | — | US | disclosed |
| US-20220380391-A1 | PROCESS FOR THE SYNTHESIS OF OLIGOMERIC SILOXANE HAVING SULFONE MOIETY, AND SILICON-CONTAINING COMPOUNDS HAVING SULFONE MOIETY | MOMENTIVE PERFORMANCE MATERIALS INC. | 2022-12-01 | — | — | US | disclosed |
| US-7544688-B2 | Hetereoaryl nitrile derivatives | NOVARTIS AG (CH) | 2009-06-09 | — | — | US | disclosed |
| US-7544688-B2 | Hetereoaryl nitrile derivatives | NOVARTIS AG (CH) | 2009-06-09 | — | — | US | disclosed |
| US-20090082457-A1 | (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide; MEK kinase (mitogen-activated ERK-activating kinases, MAP kinase kinase); cancer, tumors, autoimmune disorders, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis | ANDREA BIOSCIENCES, INC. (US) | 2009-03-26 | — | — | US | disclosed |
| WO-2009021965-A2 | SUBSTITUTED QUINOLINE DERIVATIVES AS H1 RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-02-19 | — | — | WO | disclosed |
| US-7459414-B2 | Herbicides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-7459414-B2 | Herbicides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080221171-A1 | Phenylaminopyridines | BASILEA PHARMACEUTICA AG (CH) | 2008-09-11 | — | — | US | disclosed |
| US-20080221171-A1 | Phenylaminopyridines | BASILEA PHARMACEUTICA AG (CH) | 2008-09-11 | — | — | US | disclosed |
| US-20070197571-A1 | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease | MERCK SHARP & DOHME LLC | 2007-08-23 | — | — | US | disclosed |